Your browser doesn't support javascript.
loading
The design, synthesis and properties of highly potent and selective inhibitors of herpes simplex virus types 1 and 2 thymidine kinase.
Martin, J A; Thomas, G J; Merrett, J H; Lambert, R W; Bushnell, D J; Dunsdon, S J; Freeman, A C; Hopkins, R A; Johns, I R; Keech, E; Simmonite, H; Kai-In, P W; Holland, M.
Affiliation
  • Martin JA; Department of Medicinal Chemistry, Roche Discovery Welwyn, Herts, UK. joseph.martin@roche.com
Antivir Chem Chemother ; 9(1): 1-8, 1998 Jan.
Article in En | MEDLINE | ID: mdl-9875371
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thymidine Kinase / Drug Design / Herpesvirus 2, Human / Herpesvirus 1, Human / Enzyme Inhibitors Limits: Animals / Humans Language: En Journal: Antivir Chem Chemother Journal subject: QUIMICA / TERAPIA POR MEDICAMENTOS / VIROLOGIA Year: 1998 Document type: Article Affiliation country: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thymidine Kinase / Drug Design / Herpesvirus 2, Human / Herpesvirus 1, Human / Enzyme Inhibitors Limits: Animals / Humans Language: En Journal: Antivir Chem Chemother Journal subject: QUIMICA / TERAPIA POR MEDICAMENTOS / VIROLOGIA Year: 1998 Document type: Article Affiliation country: Reino Unido